BE868843A - Compositions pour le traitement de defaillances cardiaques et de cardiopathies ischemiques - Google Patents

Compositions pour le traitement de defaillances cardiaques et de cardiopathies ischemiques

Info

Publication number
BE868843A
BE868843A BE189159A BE189159A BE868843A BE 868843 A BE868843 A BE 868843A BE 189159 A BE189159 A BE 189159A BE 189159 A BE189159 A BE 189159A BE 868843 A BE868843 A BE 868843A
Authority
BE
Belgium
Prior art keywords
compositions
treatment
heart
failures
ischemic
Prior art date
Application number
BE189159A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE868843A publication Critical patent/BE868843A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE189159A 1977-07-08 1978-07-07 Compositions pour le traitement de defaillances cardiaques et de cardiopathies ischemiques BE868843A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/814,267 US4130647A (en) 1977-07-08 1977-07-08 Methods for treating congestive heart failure and ischemic heart disease

Publications (1)

Publication Number Publication Date
BE868843A true BE868843A (fr) 1979-01-08

Family

ID=25214580

Family Applications (1)

Application Number Title Priority Date Filing Date
BE189159A BE868843A (fr) 1977-07-08 1978-07-07 Compositions pour le traitement de defaillances cardiaques et de cardiopathies ischemiques

Country Status (3)

Country Link
US (1) US4130647A (fr)
BE (1) BE868843A (fr)
PH (1) PH13965A (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532135A (en) * 1981-02-09 1985-07-30 Edwards K David G Renoprotective treatments employing vasodilator compounds
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4582832A (en) * 1984-10-09 1986-04-15 Pfizer Inc. Trimazosin as an anti-atherosclerosis agent
JPH0647540B2 (ja) * 1985-07-16 1994-06-22 エーザイ株式会社 虚血性心疾患・不整脈治療・予防剤
ZA878182B (en) * 1986-11-05 1988-05-02 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
US4868182A (en) * 1986-11-05 1989-09-19 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
US4758569A (en) * 1987-08-26 1988-07-19 Pfizer Inc. Doxazosin as an anti-atherosclerosis agent
JP2821925B2 (ja) * 1987-11-16 1998-11-05 バクスター、インターナショナル、インコーポレイテッド 有益な剤の制御された投与のためのガラス状マトリックス
US5510115A (en) * 1987-11-16 1996-04-23 Baxter Travenol Laboratories, Inc. Method and composition for administration of beneficial agent by controlled dissolution
US5030203A (en) * 1987-11-16 1991-07-09 Baxter International Inc. Ampule for controlled administration of beneficial agent
US5110927A (en) * 1987-12-31 1992-05-05 The United States Of America As Represented By The Department Of Health And Human Services Prazosin analog with increased selectivity and duration of action
US7648962B2 (en) * 2002-11-26 2010-01-19 Biocon Limited Natriuretic compounds, conjugates, and uses thereof
US20080045604A1 (en) * 2004-11-17 2008-02-21 Lindsey Berkson Composition and method for facilitating the healing of non-healing and slow-healing wounds and ulcerations
US9119615B2 (en) 2011-12-15 2015-09-01 Ethicon Endo-Surgery, Inc. Devices and methods for endoluminal plication
US9173657B2 (en) 2011-12-15 2015-11-03 Ethicon Endo-Surgery, Inc. Devices and methods for endoluminal plication
US8992547B2 (en) 2012-03-21 2015-03-31 Ethicon Endo-Surgery, Inc. Methods and devices for creating tissue plications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3669968A (en) * 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines

Also Published As

Publication number Publication date
US4130647A (en) 1978-12-19
PH13965A (en) 1980-11-12

Similar Documents

Publication Publication Date Title
FR2338687A1 (fr) Endoscope pour le traitement de strictions uretrales
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
FR2342072A1 (fr) Composition enzymatique pour le traitement de la cataracte
BE868843A (fr) Compositions pour le traitement de defaillances cardiaques et de cardiopathies ischemiques
FR2316954A1 (fr) Preparation dentaire pour le traitement de la parodontose
NO780883L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 4-acylamino-fenyl-etanolaminer
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
BE866841A (fr) Procede de preparation d'imidazoazines et -diazines substituees et leur utilisation
NO151288C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolokinolizindiner
SE7804962L (sv) Ditranolkomposition for behandling av psoriasis
BE851775A (fr) Composition pour le traitement de la chevelure
NO781879L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
RO76721A (fr) Procede pour preparer 3.12.-hydroxy-4-phenyle-cycloalcanone
BE873092A (fr) Composition pour le traitement de l'hypertension
BE885291A (fr) Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques
NO145843C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme n1-glukofuranosid-6-yl-n3-nitroso-urinstoffer
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
FR2332965A1 (fr) Formulations d'uree-polyphosphate-potassium pour le traitement du feuillage
BE856740A (fr) Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
BE871753A (fr) Nouvelle utilisation therapeutique de l'acetyl-1-carnitine pour le traitement des affections cardiaques
NO780743L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner
BE856957A (fr) Electrode pour traitement d'ionophorese
NO149314C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive imidazoisokinolindioner
BE854412A (fr) Compositions pharmaceutiques pour un traitement gynecologique
SE7602128L (sv) Legerinskompositioner

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PFIZER INC.

Effective date: 19940731